N-nonyldeoxynojirimycin

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameN-nonyldeoxynojirimycin
Drug Alias NameglucovirsNNDNJnnDNJ derivativesN-nonyl-DNJN-nonyl-deoxy-galactonojirimycin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A